Genetic changes linked with tumor include alterations in isocratic dehydrogenase (IDH), changes in epidermal growth factor receptor, platelet-derived growth factor receptor changes, aberrant epigenetic changes, and loss of heterozygosity of 1p/19q [49] (Table 5). This evidence concerns the gene IDH2 and neoplasm.